| Kyle Schimek, PHARMD | |
|
515 22nd Ave, Monroe, WI 53566-1598 | |
| (608) 324-1242 | |
| (608) 324-1726 |
| Full Name | Kyle Schimek |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 515 22nd Ave, Monroe, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255811378 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 17873-40 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kyle Schimek, PHARMD 515 22nd Ave, Monroe, WI 53566-1598 Ph: (608) 324-1242 | Kyle Schimek, PHARMD 515 22nd Ave, Monroe, WI 53566-1598 Ph: (608) 324-1242 |
News Archive
Elsevier, a world leader in healthcare and medical publishing and online solutions, today announced the availability of a new online tool within Mosby's Nursing Consult designed to help nurses prevent the 10 "Never Events" identified by the Centers for Medicare and Medicaid Services (CMS) in an October 2008 fact sheet.
Health Robotics today announced the successful global launch of the Beta Installation kick-off for its 3 latest i.v.SOFT Workflow Engine software automation modules [Assist, Label+ and Profile] in Nice [France], the 2010 venue for the European Association of Hospital Pharmacists. i.v.SOFT helps Pharmacy Technicians, I.V. Room Supervisors, and Pharmacy Directors to compound and manage the safe and efficient manual production of IV Admixtures according to hospital-defined sterile compounding guidelines, and to help bring the pharmacies into compliance with USP 797 regulations in the United States and GMP guidelines elsewhere.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.
The biological safety of nanotechnology, in other words, how the body reacts to nanoparticles, is a hot topic. Researchers at Lund University in Sweden have managed for the first time to carry out successful experiments involving the injection of so-called 'nanowires.'
A law under consideration in South Dakota would expand the definition of "justifiable homicide" to include killings that are intended to prevent harm to a fetus—a move that could make it legal to kill doctors who perform abortions.
› Verified 2 days ago
Nicole Lyn Carrico, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-1242 | |
Anna Metz, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-1242 | |
Michael Kuckes, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 W 8th St, Monroe, WI 53566 Phone: 608-325-3310 | |
Kathryn Kirmse, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1008 17th Ave, Monroe, WI 53566 Phone: 608-325-2151 Fax: 608-325-2153 | |
Dr. Stephanie Marie Garvin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-2259 | |
Kent B Pieper, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-1242 | |
Ms. Barbara Marie Cappel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-325-3111 Fax: 608-324-2439 |